Injectable Drug Delivery Resources

31. T Cell Cryopreservation: Comparing Rigid Polymer Vials And Flexible Bags 7/20/2023

    This work evaluates the performance of rigid 50 mL COP vials as an alternative for cryogenic storage of T cells compared to existing flexible cryogenic bags. The results are timely given the emerging packaging requirements and larger batch sizes anticipated for allogeneic cell therapies under clinical development.

32. Early Decisions To De-Risk The Transition To Combination Products

    The injectable product development landscape is changing, and the pressure to accelerate timelines remains constant. What can you do to overcome all the uncertainty and risk?

33. Can You Simplify Device Decisions And Stand Out From Competition? 7/25/2025

    Evaluating your system’s performance and compatibility earlier in development can ensure you have a viable product to support development phases.

34. Selecting A Prefillable Syringe System With Confidence 7/17/2026

    Prefilled syringe selection can stall drug development for months. This system integrates barrel, plunger, and needle shield from a single supplier, reducing complexity for emerging biotech.

35. Closing The Care Gap: Clinician Assistive Technologies 9/1/2025

    This technology addresses workforce shortages and growing medical complexity by helping healthcare providers manage rising demands, improve efficiency, reduce errors, and extend care access.

36. Enabling Subcutaneous Delivery For Improved Patient Compliance 3/3/2025

    The ability to administer high doses of biologics subcutaneously offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to treatment regimens.

37. Navigating PFAS "Forever Chemicals" In Medical Devices - What's On The Horizon 9/18/2024

    Gain an understanding of PFAS, their properties, environmental impact, health risks, and regulatory challenges, focusing on the specific implications for the medical device industry.

38. Component Technologies For Cartridge Delivery Applications

    Current component technologies for cartridge-based drug delivery pose challenges. In order to address these challenges, the next generation of cartridge components are evolving.

39. A Smooth Transition To USP <382> With Established Expertise 3/16/2026

    A new regulatory chapter requires holistic, real‑world testing of injectable systems, mandating full‑system validation with actual drug products and prioritizing patient‑centric performance and safety.

40. Establishing A Container Closure System — Engineering For Integrity 8/31/2026

    CCS design in aseptic manufacturing involves more than component selection. This article examines how elastomeric closures, barrier configurations, component formats, and plunger placement affect integrity and line performance.